Microbix Biosystems Inc T.MBX

Alternate Symbol(s): MBXBF

Healthcare Biotechnology

Microbix Biosystems Inc. develops and commercializes biological and technological solutions for human health and wellbeing. It enables the commercialization of diagnostic assays by making a range of critical ingredients and devices for the global diagnostics industry, notably antigens for immunoassays and its laboratory quality assessment products (QAPs) that support clinical lab proficiency testing, enable assay development and validation, or help ensure the quality of clinical diagnostic workflows. Its segments include development, manufacturing and sales of products relating to the medical diagnostics industry, namely antigens as test ingredients, quality assessment products to help ensure the accuracy of test workflows and viral transport medium to enable collection of patient test samples and, and development and commercialization of novel and proprietary products or technologies, such as Kinlytic. Its Kinlytic urokinase is a biologic thrombolytic drug used to treat blood clots.

TSX:MBX - Post by User

Microbix Biosystems Inc > 500 million revenue for Qap's

<< Previous

Bullboard Posts

Next >>

Comment by wizzdumbon Jun 30, 2022 2:25pm

178 Views

Post# 34794575

RE:RE:RE:RE:RE:RE:RE:500 million revenue for Qap's

Well said. Not losing sleep and continuing to accumulate. They will come out of this stronger than ever. Cameron is building a legacy here. He's accomplished tons already and I truly believe he will be successful. I'm happy to come along for the ride and I'm thankful I discovered this diamond in the rough before it gets recognized by the market.

<< Previous

Bullboard Posts

Next >>

Investors eye Australian gold mining projects amid promising developments